These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27737600)

  • 1. Update on bipolar disorder biomarker candidates.
    Teixeira AL; Salem H; Frey BN; Barbosa IG; Machado-Vieira R
    Expert Rev Mol Diagn; 2016 Nov; 16(11):1209-1220. PubMed ID: 27737600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel biomarkers for bipolar disorder.
    Teixeira AL; Barbosa IG; Machado-Vieira R; Rizzo LB; Wieck A; Bauer ME
    Expert Opin Med Diagn; 2013 Mar; 7(2):147-59. PubMed ID: 23530885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force.
    Frey BN; Andreazza AC; Houenou J; Jamain S; Goldstein BI; Frye MA; Leboyer M; Berk M; Malhi GS; Lopez-Jaramillo C; Taylor VH; Dodd S; Frangou S; Hall GB; Fernandes BS; Kauer-Sant'Anna M; Yatham LN; Kapczinski F; Young LT
    Aust N Z J Psychiatry; 2013 Apr; 47(4):321-32. PubMed ID: 23411094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for bipolar disorder: current status and challenges ahead.
    Teixeira AL; Colpo GD; Fries GR; Bauer IE; Selvaraj S
    Expert Rev Neurother; 2019 Jan; 19(1):67-81. PubMed ID: 30451546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals.
    Steardo L; Manchia M; Carpiniello B; Pisanu C; Steardo L; Squassina A
    Expert Rev Mol Diagn; 2020 Mar; 20(3):327-333. PubMed ID: 32054361
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value.
    Ribeiro HC; Zandonadi FDS; Sussulini A
    Expert Rev Proteomics; 2023; 20(11):267-280. PubMed ID: 37830362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.
    Pfaffenseller B; Fries GR; Wollenhaupt-Aguiar B; Colpo GD; Stertz L; Panizzutti B; Magalhães PV; Kapczinski F
    Expert Rev Neurother; 2013 Jul; 13(7):827-42. PubMed ID: 23898853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological hypotheses and biomarkers of bipolar disorder.
    Sigitova E; Fišar Z; Hroudová J; Cikánková T; Raboch J
    Psychiatry Clin Neurosci; 2017 Feb; 71(2):77-103. PubMed ID: 27800654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticolimbic connectivity as a possible biomarker for bipolar disorder.
    Vai B; Bollettini I; Benedetti F
    Expert Rev Neurother; 2014 Jun; 14(6):631-50. PubMed ID: 24852228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential biomarkers for bipolar disorder: Where do we stand?
    Sagar R; Pattanayak RD
    Indian J Med Res; 2017 Jan; 145(1):7-16. PubMed ID: 28574009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar disorder: recent advances and future trends in bioanalytical developments for biomarker discovery.
    de Jesus JR; de Campos BK; Galazzi RM; Martinez JL; Arruda MA
    Anal Bioanal Chem; 2015 Jan; 407(3):661-7. PubMed ID: 25433685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and clinical implications of functional neuroimaging in bipolar disorder.
    Brooks JO; Vizueta N
    J Psychiatr Res; 2014 Oct; 57():12-25. PubMed ID: 25015683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder.
    Kapczinski F; Dias VV; Kauer-Sant'Anna M; Brietzke E; Vázquez GH; Vieta E; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1366-71. PubMed ID: 19666076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
    Quinones MP; Kaddurah-Daouk R
    Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cytokines as an underlying mechanism of the comorbidity between bipolar disorder and migraine.
    Brietzke E; Mansur RB; Grassi-Oliveira R; Soczynska JK; McIntyre RS
    Med Hypotheses; 2012 May; 78(5):601-5. PubMed ID: 22365650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward stratified treatments for bipolar disorders.
    Hasler G; Wolf A
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):283-94. PubMed ID: 25595029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
    Martin C; Tansey KE; Schalkwyk LC; Powell TR
    Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies.
    Ghanizadeh A; Singh AB; Berk M; Torabi-Nami M
    Expert Opin Ther Targets; 2015 Jul; 19(7):927-39. PubMed ID: 25882812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.